Docebo lifts 2026 outlook on strong Q2 momentum and ARR expansion
Aug 7, 2026, 6:05 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The company raised 2026 guidance, demonstrated solid ARR growth (even when excluding the top OEM), and highlighted sizeable enterprise/government wins, all of which typically drive multiple expansion and short-term stock strength. Historically, similar raises in SaaS/LMS names tend to trigger upside on the back of improved visibility and margin progression, though long-term returns hinge on sustained ARR expansion and cash flow normalization.
AI summary
What happened, with direct paths to the underlying reporting
Docebo posted a solid Q2 2026, with revenue up 13% and ARR at $255.1m aided by FX tailwinds and acquisitions. The company reduced OEM concentration to 2.5% of ARR and raised full-year guidance, underscoring durable demand across enterprise and government sectors, including FedRAMP opportunities and public-sector wins in Kentucky, Indiana, and Mississippi. The results imply higher near-term upside and a more diversified long-term growth path for DCBO.
Q2 2026 revenue $68.7m; subscription $63.8m, up 13%/12% respectively.
ARR $255.1m at 6/30/2026; FX headwind $0.4m; ex-largest ARR +13.9% YoY.
Largest OEM = 2.5% of ARR vs 8.4% in 2025; diversification improving.
FY2026 guidance raised: subscription $255.5–257.5m; total $274.5–276.5m; Adj EBITDA $54.5–56.5m.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Docebo's enterprise value is $1.09 billion, among Canada's attractive firms. The company generated over $200 million in annual recurring revenue in 2023. Docebo's customer base in…
